Literature DB >> 22948171

Increased level of antibodies cross-reacting with Ves v 5 and CRISP-2 in MAR-positive patients.

S Brunner-Agten1, R Pavlovic, L Müller, M P Horn, A R Huber, B M Stadler, M Vogel.   

Abstract

BACKGROUND: Anti-sperm antibodies (ASA) have been described to be involved in immunological infertility. A possible antigen for ASA is the human cysteine-rich secretory protein 2 (CRISP-2), a sperm surface protein important in sperm-oocyte interaction. Furthermore, anti-CRISP-2 antibodies were shown to decrease fertility rates in vitro. Recently, we have reported cross-reacting antibodies recognizing CRISP-2 and antigen 5 from yellow jacket venom (Ves v 5) in human serum.
METHODS: Here, we investigated anti-Ves v 5 and CRISP-2 antibodies in sera from two groups of donors: MAR+ and MAR- patients.
RESULTS: A higher incidence of allergy against hymenoptera venom was found in MAR+ patients. Interestingly, affinity-purified ASA from MAR+ patients' sera reacted against both Ves v 5 and CRISP-2, leading to sperm immobilization. Immunofluorescence analysis showed that ASA bound to the sperm surface, including the head part where CRISP-2 is localized.
CONCLUSION: Taken together, these results showed a higher incidence of antibodies cross-reacting with Ves v 5 and CRISP-2 in MAR+ patients. This leads to the hypothesis that MAR+ patients may have a higher risk to develop wasp allergy.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948171     DOI: 10.1159/000338946

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  HLA antigens and anti-sperm antibody production in Iranian vasectomized men.

Authors:  Gholamreza Azizi; Saeed Namaki; Abbas Mirshafiey; Kabir Magaji Hamid
Journal:  J Biomed Res       Date:  2015-01

2.  Immune Infertility Should Be Positively Diagnosed Using an Accurate Method by Monitoring the Level of Anti-ACTL7a Antibody.

Authors:  Jun Fu; Rongyan Yao; Yanyun Luo; Dantong Yang; Yang Cao; Yi Qiu; Wei Song; Shiying Miao; Yiqun Gu; Linfang Wang
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.